Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (75)	11/5/2002 10:33:28 PM
From: Jibacoa	Read Replies (1) of 3722

DYAX Was up 24.19% on relatively low volume of 13.6K It closed just above its October 17 H of 1.53 and seems ready to test the October 16 H of 1.69 On October 29 it announced a collaboration and licensing agreement for the development of therapeutic antibodies against Thios' sulfated glycoprotein target. The Thios target is thought to play a key role as a mediator of inflammation. siliconinvestor.com siliconinvestor.com The P,S,M & L data on DYAX: 1.54, 1.34, 1.33 & 1.69 (The L is still above) Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next